Send Inquiry

Request To Call Back

ZOLDRIA ZOLEDRONIC ACID INJECTION

Get a Price/Quote

ZOLDRIA ZOLEDRONIC ACID INJECTION Specification

Salt Composition
Zoledronic Acid 5 mg

Indication
Osteoporosis, Pagets disease, malignancy-related hypercalcemia, bone metastases

Pacakaging (Quantity Per Box)
1 vial per box

Dosage Form
Injection

Origin of Medicine
Allopathic

Drug Type
Prescription

Ingredients
Zoledronic Acid

Physical Form
Liquid

Function
Prevention and treatment of osteoporosis, management of bone complications in cancer, treatment of hypercalcemia

Recommended For
Postmenopausal women with osteoporosis, patients with Pagets disease, hypercalcemia of malignancy, bone metastases

Dosage
As directed by the physician; usual adult dose is 4 mg as a single intravenous infusion

Dosage Guidelines
Administer via intravenous infusion over at least 15 minutes, medical supervision required

Suitable For
Adults

Quantity
5 mg/100 ml or as specified on packaging

Storage Instructions
Store below 30°C. Protect from light and moisture. Do not freeze.

Color
Clear colorless to pale yellow solution

Route of Administration
Intravenous infusion only

Use In Pregnancy
Contraindicated or use only if clearly needed under medical advice

Prescription Status
Prescription-only

Therapeutic Class
Bisphosphonates

Shelf Life
24 months from date of manufacture

Brand Name
Zoldria

Vial Size
100 ml vial

Administration Precautions
Monitor renal function and serum calcium before and after administration

Marketed By
Cipla

Contraindications
Hypersensitivity to Zoledronic acid, severe renal impairment

ZOLDRIA ZOLEDRONIC ACID INJECTION Trade Information

Packaging Details
PACK OF 1 VIAL

Main Domestic Market
All India

ZOLDRIA ZOLEDRONIC ACID INJECTION About

Zoldria 4mg Injection

Specifications:-

Brand: Zoldoria
Strength:4 mg
Form:Injection
Packaging Size:pack of 1 vial
Manufacturer:Cipla
Composition:Zoledronic Acid

Note :-ZoldoriaIs A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug..........

Therapeutic Efficacy for Bone Disorders

Zoldria Zoledronic Acid Injection provides significant benefit in the prevention and treatment of osteoporosis, including postmenopausal cases, and assists in managing complications such as bone metastases and malignancy-induced hypercalcemia. Its action helps reduce the risk of fractures and improves bone strength.

Administration and Usage Precautions

Administered exclusively via intravenous infusion, Zoldria should be given under strict medical supervision, with dosage tailored by a healthcare professional. Pre-administration checks include renal function and serum calcium assessments, ensuring safety. For optimal therapeutic outcomes, infuse over at least 15 minutes and monitor vital parameters before and after.

Storage and Shelf Life Considerations

Store Zoldria Injection below 30C, shielded from direct light and moisture, and never freeze the product. Its shelf life extends to 24 months from the date of manufacture, guaranteeing reliable quality when stored according to recommendations. Always refer to packaging for dosage instructions and expiry.

FAQs of ZOLDRIA ZOLEDRONIC ACID INJECTION:

Q: How should Zoldria Zoledronic Acid Injection be administered?

A: Zoldria is administered as an intravenous infusion, ideally over a period of at least 15 minutes, by a healthcare professional in a clinical setting to monitor vital parameters during and after the procedure.

Q: What conditions can Zoldria be used to treat?

A: Zoldria is prescribed for adults with osteoporosis, particularly postmenopausal women, patients with Pagets disease, malignancy-related hypercalcemia, and those suffering from bone metastases.

Q: When should renal function and serum calcium be monitored during Zoldria therapy?

A: Renal function and serum calcium levels are monitored before administering Zoldria and after the infusion to ensure patient safety and treatment effectiveness.

Q: Where should Zoldria Zoledronic Acid Injection be stored?

A: Zoldria should be stored below 30C, protected from direct light and moisture, and must not be frozen. Always check the packaging for detailed storage instructions.

Q: What are the main benefits of using Zoldria?

A: Zoldria offers robust bone protection by reducing the risk of fractures, treating bone complications related to cancer, and managing hypercalcemia. Its bisphosphonate action helps stabilize and strengthen bone structure.

Q: Who should not use Zoldria Zoledronic Acid Injection?

A: Zoldria is contraindicated for individuals with known hypersensitivity to Zoledronic Acid, severe renal impairment, and for pregnant women unless specifically advised by a physician.

Q: What precautions should be considered before starting Zoldria?

A: Ensure thorough assessment of renal function and serum calcium levels, review contraindications, and confirm suitability for intravenous infusion under medical supervision prior to initiating Zoldria therapy.

Tell us about your requirement